Gao‐Min Liu

710 total citations
16 papers, 461 citations indexed

About

Gao‐Min Liu is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Gao‐Min Liu has authored 16 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Hepatology. Recurrent topics in Gao‐Min Liu's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Ferroptosis and cancer prognosis (4 papers). Gao‐Min Liu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Ferroptosis and cancer prognosis (4 papers). Gao‐Min Liu collaborates with scholars based in China and United States. Gao‐Min Liu's co-authors include Jiwei Xu, Caiyun Zhang, Huadong Zeng, Wenxuan Xie, Yaoming Zhang, Baogang Peng, Wenjie Hu, Shunli Shen, Xiaoyong Huang and Бин Чэн and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cellular Physiology and Cell Death and Disease.

In The Last Decade

Gao‐Min Liu

14 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gao‐Min Liu China	9	267	232	163	87	79	16	461
Irene Casanova‐Salas Spain	10	311 1.2×	302 1.3×	182 1.1×	77 0.9×	114 1.4×	27	623
Jiwei Xu China	8	253 0.9×	193 0.8×	154 0.9×	66 0.8×	37 0.5×	22	415
Yirui Yin China	11	206 0.8×	136 0.6×	84 0.5×	78 0.9×	41 0.5×	23	343
Yunong Fu China	12	358 1.3×	307 1.3×	118 0.7×	67 0.8×	27 0.3×	16	479
Fangfeng Liu China	14	414 1.6×	386 1.7×	100 0.6×	86 1.0×	29 0.4×	26	552
Wen-Kai Shi China	5	212 0.8×	185 0.8×	63 0.4×	102 1.2×	148 1.9×	8	435
Zongqiang Hu China	11	377 1.4×	298 1.3×	106 0.7×	62 0.7×	53 0.7×	16	514
Kwan Man Hong Kong	5	543 2.0×	199 0.9×	51 0.3×	73 0.8×	83 1.1×	5	688
Sara Torrecilla United States	6	252 0.9×	206 0.9×	96 0.6×	121 1.4×	212 2.7×	10	512
Shifeng Xu China	12	239 0.9×	177 0.8×	109 0.7×	143 1.6×	29 0.4×	22	456

Countries citing papers authored by Gao‐Min Liu

Since Specialization

Citations

This map shows the geographic impact of Gao‐Min Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gao‐Min Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gao‐Min Liu more than expected).

Fields of papers citing papers by Gao‐Min Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gao‐Min Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gao‐Min Liu. The network helps show where Gao‐Min Liu may publish in the future.

Co-authorship network of co-authors of Gao‐Min Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Gao‐Min Liu. A scholar is included among the top collaborators of Gao‐Min Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gao‐Min Liu. Gao‐Min Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Liu, Gao‐Min, Rui Guo, & Jiwei Xu. (2025). A bibliometric and visual analysis based on immune checkpoint inhibitors for hepatocellular carcinoma: 2014 – 2024. Frontiers in Pharmacology. 16. 1520055–1520055.

Liu, Gao‐Min, Xiaoyu Ding, Lijun Xue, et al.. (2024). miR-520e and its promoter region DNA methylation as potential biomarkers in atherosclerosis. Biochemistry and Cell Biology. 102(5). 385–393. 1 indexed citations

Liu, Gao‐Min, et al.. (2024). Advanced lung cancer inflammation index predicts overall survival of hepatocellular carcinoma after hepatectomy. Frontiers in Oncology. 14. 1294253–1294253. 4 indexed citations

Xu, Jiwei, et al.. (2024). Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess. Journal of Visualized Experiments.

Liu, Gao‐Min, et al.. (2024). Triglyceride-glucose index predicts postoperative overall survival in hepatocellular carcinoma: a retrospective cohort study. Discover Oncology. 15(1). 651–651. 1 indexed citations

Liu, Gao‐Min, et al.. (2022). 85P Tislelizumab combined with apatinib and oxaliplatin plus S1 as neoadjuvant therapy for Borrmann IV large Borrmann III type and bulky N positive advanced gastric cancer: A single-arm multicenter trial (TAOS-3B-Trial). Immuno-Oncology Technology. 16. 100189–100189. 6 indexed citations

Liu, Gao‐Min, Jia Li, Caiyun Zhang, Dongyang Huang, & Jiwei Xu. (2021). ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway. SHILAP Revista de lepidopterología. Volume 8. 271–284. 8 indexed citations

Wei, Chunyang, Xiuwen Tan, Gao‐Min Liu, et al.. (2020). β-carotene as a dietary factor affecting expression of genes connected with carotenoid, vitamin A and lipid metabolism in the subcutaneous and omental adipose tissue of beef cattle. Journal of Animal and Feed Sciences. 29(1). 11–18. 6 indexed citations

Liu, Gao‐Min, Huadong Zeng, Caiyun Zhang, & Jiwei Xu. (2020). Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 66(4). 1110–1126. 52 indexed citations

10.

Liu, Gao‐Min, Huadong Zeng, Caiyun Zhang, & Jiwei Xu. (2019). Key genes associated with diabetes mellitus and hepatocellular carcinoma. Pathology - Research and Practice. 215(11). 152510–152510. 38 indexed citations

11.

Liu, Gao‐Min, et al.. (2019). Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis. Cancer Cell International. 19(1). 22–22. 28 indexed citations

12.

Liu, Gao‐Min, et al.. (2019). Identification of a four‐gene metabolic signature predicting overall survival for hepatocellular carcinoma. Journal of Cellular Physiology. 235(2). 1624–1636. 77 indexed citations

13.

Liu, Gao‐Min, Huadong Zeng, Caiyun Zhang, & Jiwei Xu. (2019). Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Cancer Cell International. 19(1). 138–138. 128 indexed citations

14.

Liu, Gao‐Min & Yaoming Zhang. (2018). Targeting FBPase is an emerging novel approach for cancer therapy. Cancer Cell International. 18(1). 36–36. 38 indexed citations

15.

Liu, Gao‐Min, Qiao Li, Pengfei Zhang, et al.. (2018). Restoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma. Cell Death and Disease. 9(11). 1132–1132. 42 indexed citations

16.

Liu, Gao‐Min, Xiaoyong Huang, Shunli Shen, Wenjie Hu, & Baogang Peng. (2015). Adjuvant antiviral therapy for hepatitis B virus‐related hepatocellular carcinoma after curative treatment: A systematic review and meta‐analysis. Hepatology Research. 46(1). 100–110. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact